The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

orthorebirth.com

Founded Year

2011

Stage

Corporate Minority - III | Alive

Total Raised

$8.93M

Last Raised

$6.27M | 3 yrs ago

About ORTHOReBIRTH

ORTHOReBIRTH develops ReBOSSIS, a cottony-type, bioabsorbable, synthetic bone-void-filling material with electrospun microfiber construction.

ORTHOReBIRTH Headquarter Location

15-3-303 Chigasaki-Chuo Tsuzuki-ku

Yokohama, 224-0032,

Japan

+81-(0)45-532-3650

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ORTHOReBIRTH

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ORTHOReBIRTH is included in 2 Expert Collections, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

ORTHOReBIRTH Patents

ORTHOReBIRTH has filed 15 patents.

The 3 most popular patent topics include:

  • Polymers
  • Biomaterials
  • Skeletal system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/20/2018

10/27/2020

Biomaterials, Oral and maxillofacial surgery, Calcium minerals, Oral surgery, Polymers

Grant

Application Date

12/20/2018

Grant Date

10/27/2020

Title

Related Topics

Biomaterials, Oral and maxillofacial surgery, Calcium minerals, Oral surgery, Polymers

Status

Grant

Latest ORTHOReBIRTH News

ORTHOReBIRTH USA partners with Adventist Health System

Nov 21, 2018

Written by Shayna Korol | November 21, 2018 | Print  | Email ORTHOReBIRTH USA and Altamonte Springs, Fla.-based Adventist Health System Sunbelt Healthcare Corp. entered into a product agreement. ORTHOReBIRTH USA markets ReBOSSIS, the only biosynthetic scaffold with electrospun microfiber construction designed to support cell activation, retention and proliferation. The orthobiologics company recently  signed  a letter of intent to develop new biologics products with neurosurgeon Loubert S. Suddaby, MD. Adventist Health System is a faith-based healthcare system comprised of 48 hospital campuses with more than 80,000 employees. More articles on biologics:

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.